AI
NTUS

Axiom Investors’s Natus Medical Inc NTUS Stock Holding History

Axiom Investors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-93,520
Closed -$3.37M – 170
2014
Q4 		$3.37M Buy
+93,520
New +$3.14M 0.08% 87

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Axiom Investors's NTUS Position: Q1 2015 in Review

Axiom Investors sold out of Natus Medical Inc (NTUS) in Q1 2015, closing a stake of 93,520 shares — an estimated $3.37M sold.

Axiom Investors first reported a position in NTUS in Q4 2014 and held it in 1 quarter. The position peaked at $3.37M in Q4 2014. 205 funds tracked by Wall St. Rank hold NTUS as of Q1 2015.

  • Axiom Investors reported no remaining Natus Medical Inc position as of Q1 2015 after selling out during the quarter.
  • Axiom Investors sold 93,520 Natus Medical Inc shares in Q1 2015, an estimated $3.37M.
  • Axiom Investors first reported a position in Natus Medical Inc in Q4 2014 and held it in 1 quarter.
  • Axiom Investors's Natus Medical Inc position peaked at $3.37M in Q4 2014.
  • 205 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2015.

Based on Axiom Investors's 13F filing for Q1 2015, filed 13 May 2015.